D
Doc and Tell
Glossary/compliance
compliance

Clinical Data Package

The complete set of clinical trial results and analyses submitted to regulatory agencies to support a drug or device approval application.

A clinical data package for a major drug approval typically includes: Phase 1 safety and pharmacokinetics studies; Phase 2 dose-finding and preliminary efficacy studies; Phase 3 pivotal controlled trials demonstrating substantial evidence of efficacy; long-term safety data from open-label extension studies; and integrated summaries of safety and efficacy across all studies. The package must demonstrate that the benefit-risk profile of the drug is favorable for the proposed indication and patient population.

Regulatory agencies (FDA, EMA, TGA, PMDA) review the clinical data package against the applicable regulatory guidance for the specific indication. The statistical analysis of the primary endpoint — typically a pre-specified analysis plan submitted before the trial is unblinded — is the centerpiece of the submission. Document intelligence applied to large clinical data packages enables teams to rapidly locate specific study protocols, endpoint definitions, statistical analysis plans, and safety narratives across hundreds of clinical study reports.

Analyze Documents Related to Clinical Data Package

Upload any document and get AI-powered analysis with verifiable citations.

Start Free